Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Garcia-Sastre Laboratory 

icahn.mssm.edu   /   Inside Mount Sinai Blog

Menu

Skip to content
  • Home
  • People
  • Research
    • Influenza Virus
    • Oncolytic Viruses
    • Type I IFN
    • Viral IFN Antagonists
  • Publications
  • Contact

Francesca di Domenico

Ph.D. Student
francesca.di.domenico@icahn.mssm.edu

RSS Recent Publications

  • Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine May 18, 2022 Aitor Nogales
  • Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam May 16, 2022 Anh Duc Dang
  • Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer May 3, 2022 Philip C Mack
  • Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial April 24, 2022 Nicolas Folschweiller
  • Right Ventricular Abnormality in Patients Hospitalized With COVID-19 Infection During Omicron Variant Surge April 23, 2022 Alaa Mabrouk Salem Omar
  • Defining the risk of SARS-CoV-2 variants on immune protection April 1, 2022 Marciela M DeGrace
  • Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice March 30, 2022 Irene González-Domínguez
  • Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2 March 25, 2022 Lucy G Thorne
  • Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial March 14, 2022 Punnee Pitisuttithum
  • The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity March 9, 2022 Adam Hage
  • Limited extent and consequences of pancreatic SARS-CoV-2 infection March 5, 2022 Verena van der Heide
  • Human SUMOylation Pathway Is Critical for Influenza B Virus February 26, 2022 Runrui Dang
  • Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations February 21, 2022 Noah Peña
  • The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters February 16, 2022 Lisa Miorin
  • Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico February 16, 2022 Samuel Ponce-de-León

Upcoming Events

Click here to view a calendar with upcoming events.

Careers | Contact Us | Privacy | Legal
800-MD-SINAI
© Icahn School of Medicine at Mount Sinai